These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The FORKO mouse as a genetic model for exploring estrogen replacement therapy. Sairam MR, Danilovich N, Lussier-Cacan S. J Reprod Med; 2002 May 10; 47(5):412-8. PubMed ID: 12063881 [Abstract] [Full Text] [Related]
6. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D. Ear Hear; 2008 Dec 10; 29(6):875-93. PubMed ID: 18753950 [Abstract] [Full Text] [Related]
7. Effects of continuous and intermittent estrogen treatments on memory in aging female mice. Gresack JE, Frick KM. Brain Res; 2006 Oct 18; 1115(1):135-47. PubMed ID: 16920082 [Abstract] [Full Text] [Related]
8. A clinical study of the efferent auditory system in patients with normal hearing who have acute tinnitus. Riga M, Papadas T, Werner JA, Dalchow CV. Otol Neurotol; 2007 Feb 18; 28(2):185-90. PubMed ID: 17255885 [Abstract] [Full Text] [Related]
9. Potential ototoxicity of aluminum in hemodialysis patients. Chu PL, Wu CC, Hsu CJ, Wang YT, Wu KD. Laryngoscope; 2007 Jan 18; 117(1):137-41. PubMed ID: 17202943 [Abstract] [Full Text] [Related]
10. Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children. Ugur AK, Kemaloglu YK, Ugur MB, Gunduz B, Saridogan C, Yesilkaya E, Bideci A, Cinaz P, Goksu N. Int J Pediatr Otorhinolaryngol; 2009 Apr 18; 73(4):555-9. PubMed ID: 19150138 [Abstract] [Full Text] [Related]
12. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions. Riga M, Korres S, Psarommatis I, Varvutsi M, Giotakis I, Papadas T, Ferekidis E, Apostolopoulos N. Otol Neurotol; 2007 Feb 18; 28(2):208-12. PubMed ID: 17255889 [Abstract] [Full Text] [Related]
16. Distortion product otoacoustic emission contralateral suppression functions obtained with ramped stimuli. Purcell DW, Butler BE, Saunders TJ, Allen P. J Acoust Soc Am; 2008 Oct 18; 124(4):2133-48. PubMed ID: 19062854 [Abstract] [Full Text] [Related]
17. Amplitude modulation of DPOAEs by acoustic stimulation of the contralateral ear. Harrison RV, Sharma A, Brown T, Jiwani S, James AL. Acta Otolaryngol; 2008 Apr 18; 128(4):404-7. PubMed ID: 18368574 [Abstract] [Full Text] [Related]
18. Sex differences in expression and differential regulation by androgen and estrogen of two odorant-binding tear lipocalins in lacrimal glands of immature hamsters. Srikantan S, De PK. Gen Comp Endocrinol; 2008 Sep 15; 158(3):268-76. PubMed ID: 18703064 [Abstract] [Full Text] [Related]
19. Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study. Job A, Raynal M, Kossowski M, Studler M, Ghernaouti C, Baffioni-Venturi A, Roux A, Darolles C, Guelorget A. Hear Res; 2009 May 15; 251(1-2):10-6. PubMed ID: 19249340 [Abstract] [Full Text] [Related]
20. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults. Dreisbach LE, Long KM, Lees SE. Ear Hear; 2006 Oct 15; 27(5):466-79. PubMed ID: 16957498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]